 Andrew Bradford
Concepts (385)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endometrial Neoplasms | 7 | 2021 | 196 | 1.690 |
Why?
| | Follicle Stimulating Hormone | 13 | 2023 | 243 | 1.600 |
Why?
| | E2F1 Transcription Factor | 10 | 2025 | 64 | 1.590 |
Why?
| | Luteinizing Hormone | 13 | 2022 | 183 | 1.450 |
Why?
| | Prolactin | 10 | 2022 | 96 | 1.040 |
Why?
| | Hyperlipidemias | 3 | 2022 | 124 | 0.990 |
Why?
| | Obesity | 16 | 2024 | 2962 | 0.970 |
Why?
| | Hyperinsulinism | 3 | 2022 | 122 | 0.970 |
Why?
| | Leiomyoma | 3 | 2019 | 55 | 0.960 |
Why?
| | Uterine Neoplasms | 3 | 2019 | 91 | 0.930 |
Why?
| | Protein Kinase C-alpha | 3 | 2009 | 37 | 0.870 |
Why?
| | Metabolic Syndrome | 4 | 2024 | 346 | 0.810 |
Why?
| | Pituitary Gland | 7 | 2021 | 150 | 0.810 |
Why?
| | Promoter Regions, Genetic | 17 | 2025 | 1233 | 0.790 |
Why?
| | Human Growth Hormone | 1 | 2022 | 48 | 0.730 |
Why?
| | Proto-Oncogene Proteins | 9 | 2015 | 620 | 0.720 |
Why?
| | Gene Expression Profiling | 6 | 2019 | 1746 | 0.700 |
Why?
| | Corpus Luteum | 3 | 2016 | 20 | 0.700 |
Why?
| | Soybean Oil | 1 | 2021 | 14 | 0.700 |
Why?
| | Protein Kinase C-delta | 5 | 2009 | 48 | 0.690 |
Why?
| | Gene Expression Regulation, Neoplastic | 10 | 2025 | 1388 | 0.670 |
Why?
| | Phospholipids | 2 | 2021 | 219 | 0.640 |
Why?
| | Leiomyosarcoma | 1 | 2019 | 28 | 0.610 |
Why?
| | Cell Proliferation | 8 | 2024 | 2480 | 0.550 |
Why?
| | Insulin | 5 | 2022 | 2448 | 0.520 |
Why?
| | Apoptosis | 11 | 2024 | 2546 | 0.510 |
Why?
| | Fibroblast Growth Factors | 4 | 2021 | 178 | 0.510 |
Why?
| | Gene Expression Regulation | 11 | 2023 | 2590 | 0.500 |
Why?
| | Diet, High-Fat | 3 | 2024 | 247 | 0.490 |
Why?
| | High Fructose Corn Syrup | 1 | 2015 | 8 | 0.480 |
Why?
| | Granulosa Cells | 1 | 2015 | 33 | 0.470 |
Why?
| | Signal Transduction | 11 | 2021 | 5086 | 0.460 |
Why?
| | Weight Gain | 2 | 2016 | 532 | 0.450 |
Why?
| | Proto-Oncogene Proteins c-ets | 8 | 2007 | 56 | 0.440 |
Why?
| | Gene Products, tax | 2 | 2024 | 13 | 0.440 |
Why?
| | DEAD-box RNA Helicases | 2 | 2025 | 73 | 0.440 |
Why?
| | Human T-lymphotropic virus 1 | 2 | 2024 | 28 | 0.440 |
Why?
| | Fibroblast Growth Factor 2 | 3 | 2006 | 87 | 0.420 |
Why?
| | Dietary Fats | 1 | 2015 | 299 | 0.410 |
Why?
| | Adenocarcinoma | 3 | 2009 | 885 | 0.400 |
Why?
| | Transcription Factors | 8 | 2018 | 1697 | 0.380 |
Why?
| | MAP Kinase Signaling System | 3 | 2006 | 322 | 0.380 |
Why?
| | Biomarkers, Tumor | 1 | 2019 | 1224 | 0.380 |
Why?
| | DNA-Binding Proteins | 8 | 2018 | 1471 | 0.370 |
Why?
| | Cell Line, Tumor | 12 | 2025 | 3392 | 0.360 |
Why?
| | MicroRNAs | 2 | 2015 | 675 | 0.350 |
Why?
| | Gonadotropins | 3 | 2023 | 40 | 0.350 |
Why?
| | E2F Transcription Factors | 4 | 2023 | 60 | 0.350 |
Why?
| | Protein Kinase C | 2 | 2003 | 252 | 0.350 |
Why?
| | Aromatase Inhibitors | 3 | 2020 | 58 | 0.340 |
Why?
| | Cross-Over Studies | 3 | 2022 | 556 | 0.340 |
Why?
| | Fibroblast Growth Factor 4 | 3 | 2006 | 19 | 0.330 |
Why?
| | Homeodomain Proteins | 5 | 2012 | 509 | 0.320 |
Why?
| | Estradiol | 5 | 2023 | 525 | 0.310 |
Why?
| | Female | 36 | 2024 | 73763 | 0.300 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 159 | 0.300 |
Why?
| | Transcriptional Activation | 4 | 2024 | 376 | 0.300 |
Why?
| | RNA, Messenger | 2 | 2015 | 2815 | 0.280 |
Why?
| | Hydrocortisone | 2 | 2022 | 314 | 0.270 |
Why?
| | Tumor Suppressor Protein p53 | 2 | 2024 | 525 | 0.270 |
Why?
| | Retinoblastoma Protein | 2 | 2025 | 57 | 0.260 |
Why?
| | Humans | 47 | 2025 | 138651 | 0.260 |
Why?
| | Menstrual Cycle | 2 | 2019 | 133 | 0.250 |
Why?
| | Ovarian Neoplasms | 1 | 2012 | 562 | 0.250 |
Why?
| | Growth Hormone | 3 | 2022 | 102 | 0.240 |
Why?
| | Genes, Tumor Suppressor | 4 | 2023 | 80 | 0.240 |
Why?
| | Isoenzymes | 3 | 2003 | 303 | 0.240 |
Why?
| | Cytokines | 4 | 2024 | 2080 | 0.230 |
Why?
| | Cell Cycle Proteins | 4 | 2023 | 616 | 0.230 |
Why?
| | Weight Loss | 2 | 2024 | 783 | 0.230 |
Why?
| | Protein-Arginine N-Methyltransferases | 1 | 2024 | 25 | 0.210 |
Why?
| | Adipokines | 1 | 2024 | 47 | 0.210 |
Why?
| | Tumor Cells, Cultured | 5 | 2007 | 956 | 0.210 |
Why?
| | Live Birth | 1 | 2024 | 65 | 0.210 |
Why?
| | Phosphorylation | 5 | 2024 | 1760 | 0.210 |
Why?
| | Preconception Care | 1 | 2024 | 42 | 0.210 |
Why?
| | Cyclin-Dependent Kinases | 1 | 2024 | 131 | 0.200 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2016 | 122 | 0.200 |
Why?
| | Persian Gulf Syndrome | 1 | 2023 | 17 | 0.200 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2003 | 58 | 0.200 |
Why?
| | Transcription Factor DP1 | 2 | 2023 | 21 | 0.200 |
Why?
| | Irritable Bowel Syndrome | 1 | 2023 | 29 | 0.200 |
Why?
| | Gonadotropin-Releasing Hormone | 4 | 2021 | 212 | 0.190 |
Why?
| | Fertility | 1 | 2024 | 163 | 0.190 |
Why?
| | Pituitary Hormones | 1 | 2022 | 16 | 0.190 |
Why?
| | Rats | 10 | 2006 | 5594 | 0.190 |
Why?
| | Transcription Factor Pit-1 | 6 | 2003 | 27 | 0.180 |
Why?
| | Thyroid Hormones | 1 | 2022 | 60 | 0.180 |
Why?
| | Hypothalamus | 2 | 2014 | 153 | 0.180 |
Why?
| | Thyrotropin | 1 | 2022 | 117 | 0.180 |
Why?
| | Transcription, Genetic | 3 | 2009 | 1470 | 0.180 |
Why?
| | Mindfulness | 1 | 2024 | 145 | 0.180 |
Why?
| | Animals | 19 | 2016 | 37217 | 0.180 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 3 | 1997 | 262 | 0.180 |
Why?
| | Emulsions | 1 | 2021 | 55 | 0.170 |
Why?
| | Tandem Mass Spectrometry | 2 | 2015 | 555 | 0.170 |
Why?
| | Gastrointestinal Diseases | 1 | 2023 | 206 | 0.170 |
Why?
| | Thinness | 1 | 2021 | 95 | 0.170 |
Why?
| | Heparin | 1 | 2022 | 258 | 0.170 |
Why?
| | Leptin | 1 | 2022 | 242 | 0.170 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2021 | 158 | 0.160 |
Why?
| | Gastroesophageal Reflux | 1 | 2023 | 242 | 0.160 |
Why?
| | Wnt Proteins | 1 | 2021 | 135 | 0.160 |
Why?
| | Adiponectin | 1 | 2022 | 240 | 0.160 |
Why?
| | Creatinine | 1 | 2022 | 486 | 0.160 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p18 | 2 | 2016 | 15 | 0.160 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 2 | 2012 | 175 | 0.160 |
Why?
| | Enzyme Activation | 3 | 2009 | 810 | 0.160 |
Why?
| | Proto-Oncogene Protein c-ets-1 | 6 | 2003 | 25 | 0.160 |
Why?
| | Bcl-2-Like Protein 11 | 2 | 2016 | 38 | 0.160 |
Why?
| | Feasibility Studies | 1 | 2024 | 980 | 0.160 |
Why?
| | Adult | 17 | 2024 | 38201 | 0.160 |
Why?
| | Lipids | 2 | 2022 | 675 | 0.160 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2022 | 325 | 0.160 |
Why?
| | Chitinase-3-Like Protein 1 | 1 | 2019 | 19 | 0.160 |
Why?
| | Cell Cycle | 2 | 2015 | 592 | 0.150 |
Why?
| | Intramolecular Oxidoreductases | 1 | 2019 | 68 | 0.150 |
Why?
| | Wnt Signaling Pathway | 1 | 2021 | 196 | 0.150 |
Why?
| | Biomarkers | 2 | 2024 | 4092 | 0.150 |
Why?
| | beta Catenin | 1 | 2021 | 252 | 0.150 |
Why?
| | Eicosapentaenoic Acid | 1 | 2019 | 38 | 0.150 |
Why?
| | Cytoskeletal Proteins | 1 | 2019 | 156 | 0.150 |
Why?
| | Follicular Phase | 2 | 2015 | 39 | 0.140 |
Why?
| | Docosahexaenoic Acids | 1 | 2019 | 86 | 0.140 |
Why?
| | Gene Knockdown Techniques | 2 | 2009 | 329 | 0.140 |
Why?
| | Microtubule-Associated Proteins | 1 | 2019 | 195 | 0.140 |
Why?
| | Estrone | 2 | 2015 | 36 | 0.140 |
Why?
| | Immunoenzyme Techniques | 2 | 2009 | 209 | 0.140 |
Why?
| | Estrogens | 3 | 2019 | 365 | 0.140 |
Why?
| | Pituitary Gland, Anterior | 1 | 1997 | 38 | 0.140 |
Why?
| | Etoposide | 2 | 2009 | 162 | 0.140 |
Why?
| | Genes, p16 | 1 | 2016 | 15 | 0.130 |
Why?
| | Pregnancy | 4 | 2024 | 6829 | 0.130 |
Why?
| | Fibroblasts | 3 | 2018 | 1003 | 0.130 |
Why?
| | Aromatase | 2 | 2014 | 32 | 0.130 |
Why?
| | Oncogene Proteins | 1 | 1996 | 58 | 0.120 |
Why?
| | Genes, ras | 2 | 1997 | 94 | 0.120 |
Why?
| | Stress, Psychological | 1 | 2024 | 1119 | 0.120 |
Why?
| | Blotting, Western | 2 | 2009 | 1230 | 0.120 |
Why?
| | Ovulation | 1 | 2015 | 40 | 0.120 |
Why?
| | Young Adult | 10 | 2024 | 13305 | 0.120 |
Why?
| | RNA-Binding Proteins | 1 | 2019 | 431 | 0.120 |
Why?
| | Molecular Sequence Annotation | 1 | 2015 | 95 | 0.120 |
Why?
| | Cumulus Cells | 1 | 2015 | 6 | 0.120 |
Why?
| | Dietary Supplements | 2 | 2019 | 553 | 0.120 |
Why?
| | Diagnosis, Differential | 1 | 2019 | 1482 | 0.110 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2023 | 850 | 0.110 |
Why?
| | Transcription Factors, TFII | 2 | 2024 | 41 | 0.110 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2016 | 368 | 0.110 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2015 | 192 | 0.110 |
Why?
| | Tumor Suppressor Protein p14ARF | 1 | 2014 | 7 | 0.110 |
Why?
| | Sensitivity and Specificity | 1 | 2019 | 1941 | 0.110 |
Why?
| | Blood Chemical Analysis | 1 | 2015 | 110 | 0.110 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2015 | 139 | 0.110 |
Why?
| | Hormone Antagonists | 1 | 2014 | 34 | 0.110 |
Why?
| | Luteal Phase | 1 | 2014 | 46 | 0.110 |
Why?
| | Hypogonadism | 3 | 2024 | 92 | 0.100 |
Why?
| | Transfection | 3 | 2009 | 941 | 0.100 |
Why?
| | Repressor Proteins | 1 | 1997 | 420 | 0.100 |
Why?
| | Neoplasms, Experimental | 1 | 2014 | 174 | 0.100 |
Why?
| | Circadian Rhythm | 1 | 2017 | 489 | 0.100 |
Why?
| | RNA Interference | 2 | 2018 | 468 | 0.100 |
Why?
| | Postmenopause | 1 | 2015 | 370 | 0.100 |
Why?
| | Culture Media, Serum-Free | 2 | 2003 | 46 | 0.100 |
Why?
| | Exercise | 1 | 2024 | 2072 | 0.100 |
Why?
| | DNA Fingerprinting | 1 | 2012 | 29 | 0.100 |
Why?
| | Base Sequence | 3 | 2012 | 2174 | 0.100 |
Why?
| | RNA, Small Interfering | 2 | 2018 | 626 | 0.090 |
Why?
| | Breast Neoplasms | 3 | 2012 | 2212 | 0.090 |
Why?
| | Cell Line | 5 | 2018 | 2876 | 0.090 |
Why?
| | DNA, Complementary | 2 | 2012 | 274 | 0.090 |
Why?
| | Tumor Suppressor Proteins | 1 | 2014 | 320 | 0.090 |
Why?
| | Veterans | 1 | 2023 | 1486 | 0.090 |
Why?
| | Testosterone | 1 | 2015 | 402 | 0.090 |
Why?
| | Pulsatile Flow | 1 | 2011 | 55 | 0.090 |
Why?
| | Protein Isoforms | 2 | 2003 | 395 | 0.080 |
Why?
| | Cell Survival | 2 | 2021 | 1123 | 0.080 |
Why?
| | Pituitary Neoplasms | 2 | 2003 | 192 | 0.080 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 984 | 0.080 |
Why?
| | Adiposity | 1 | 2015 | 519 | 0.080 |
Why?
| | Mutation | 1 | 2021 | 3987 | 0.080 |
Why?
| | Colony-Forming Units Assay | 1 | 2009 | 96 | 0.080 |
Why?
| | Neoplasms | 2 | 2023 | 2681 | 0.080 |
Why?
| | Infertility, Female | 2 | 2024 | 107 | 0.080 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2009 | 74 | 0.080 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2009 | 73 | 0.080 |
Why?
| | Luciferases | 1 | 2009 | 150 | 0.080 |
Why?
| | Transforming Growth Factor beta | 1 | 2012 | 488 | 0.080 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2009 | 82 | 0.080 |
Why?
| | Progesterone | 3 | 2016 | 258 | 0.080 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2015 | 761 | 0.080 |
Why?
| | Inflammation | 2 | 2024 | 2850 | 0.080 |
Why?
| | Models, Biological | 2 | 2016 | 1806 | 0.080 |
Why?
| | Cyclin D1 | 1 | 2009 | 68 | 0.080 |
Why?
| | Mutant Proteins | 1 | 2009 | 102 | 0.070 |
Why?
| | NIH 3T3 Cells | 1 | 2009 | 148 | 0.070 |
Why?
| | Membrane Proteins | 1 | 2015 | 1145 | 0.070 |
Why?
| | Matrix Metalloproteinase 11 | 1 | 2008 | 4 | 0.070 |
Why?
| | PTEN Phosphohydrolase | 1 | 2009 | 163 | 0.070 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2012 | 540 | 0.070 |
Why?
| | RNA, Neoplasm | 1 | 2008 | 79 | 0.070 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2009 | 280 | 0.070 |
Why?
| | Myometrium | 1 | 2008 | 39 | 0.070 |
Why?
| | Neoplastic Stem Cells | 1 | 2012 | 396 | 0.070 |
Why?
| | Rabbits | 1 | 2009 | 747 | 0.070 |
Why?
| | DNA, Neoplasm | 1 | 2008 | 157 | 0.070 |
Why?
| | Mice, Nude | 1 | 2009 | 688 | 0.070 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2024 | 1518 | 0.070 |
Why?
| | Cell Adhesion | 1 | 2009 | 466 | 0.070 |
Why?
| | Neoplasm Invasiveness | 1 | 2009 | 501 | 0.070 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2007 | 121 | 0.070 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2009 | 442 | 0.070 |
Why?
| | DNA Primers | 1 | 2008 | 508 | 0.070 |
Why?
| | Subcellular Fractions | 1 | 2006 | 78 | 0.060 |
Why?
| | HeLa Cells | 2 | 2000 | 637 | 0.060 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2016 | 68 | 0.060 |
Why?
| | Proto-Oncogene Proteins c-raf | 2 | 1997 | 44 | 0.060 |
Why?
| | Mammary Glands, Human | 1 | 2007 | 65 | 0.060 |
Why?
| | Immunoprecipitation | 1 | 2006 | 154 | 0.060 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2006 | 98 | 0.060 |
Why?
| | DNA Damage | 1 | 2009 | 422 | 0.060 |
Why?
| | Ultraviolet Rays | 1 | 2009 | 397 | 0.060 |
Why?
| | Growth Hormone-Releasing Hormone | 1 | 2006 | 25 | 0.060 |
Why?
| | raf Kinases | 1 | 2006 | 12 | 0.060 |
Why?
| | Autocrine Communication | 1 | 2006 | 40 | 0.060 |
Why?
| | Receptors, Growth Factor | 1 | 2006 | 56 | 0.060 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1997 | 174 | 0.060 |
Why?
| | Middle Aged | 3 | 2024 | 33604 | 0.060 |
Why?
| | Protein Kinase Inhibitors | 2 | 2009 | 907 | 0.060 |
Why?
| | Prostate | 1 | 2007 | 173 | 0.060 |
Why?
| | Paracrine Communication | 1 | 2006 | 66 | 0.060 |
Why?
| | Caspases | 1 | 2006 | 245 | 0.060 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2006 | 190 | 0.060 |
Why?
| | Reproduction | 1 | 2007 | 202 | 0.060 |
Why?
| | ras Proteins | 1 | 2006 | 148 | 0.060 |
Why?
| | Prospective Studies | 4 | 2023 | 7554 | 0.060 |
Why?
| | Adolescent | 7 | 2021 | 21564 | 0.060 |
Why?
| | Protein Binding | 2 | 2024 | 2225 | 0.060 |
Why?
| | Hypothalamo-Hypophyseal System | 2 | 2017 | 205 | 0.060 |
Why?
| | Mice | 4 | 2012 | 17814 | 0.060 |
Why?
| | Cell Movement | 1 | 2009 | 969 | 0.060 |
Why?
| | Oncogene Protein p65(gag-jun) | 1 | 2004 | 2 | 0.060 |
Why?
| | Pituitary Hormones, Anterior | 1 | 2024 | 7 | 0.050 |
Why?
| | Ideal Body Weight | 1 | 2024 | 4 | 0.050 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2006 | 316 | 0.050 |
Why?
| | Cyclin D2 | 1 | 2024 | 5 | 0.050 |
Why?
| | Ovulation Induction | 2 | 2015 | 58 | 0.050 |
Why?
| | Cyclin-Dependent Kinase 2 | 1 | 2024 | 39 | 0.050 |
Why?
| | Cell Nucleus | 1 | 2007 | 607 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 2004 | 57 | 0.050 |
Why?
| | Body Mass Index | 3 | 2021 | 2349 | 0.050 |
Why?
| | Jurkat Cells | 1 | 2024 | 138 | 0.050 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2024 | 80 | 0.050 |
Why?
| | Diet, Fat-Restricted | 1 | 2024 | 78 | 0.050 |
Why?
| | Pregnancy Rate | 1 | 2024 | 67 | 0.050 |
Why?
| | Thiocarbamates | 1 | 2003 | 6 | 0.050 |
Why?
| | Gene Expression | 2 | 2021 | 1488 | 0.050 |
Why?
| | Phospholipid Ethers | 1 | 2003 | 7 | 0.050 |
Why?
| | Bridged-Ring Compounds | 1 | 2003 | 14 | 0.050 |
Why?
| | Thiones | 1 | 2003 | 14 | 0.050 |
Why?
| | Norbornanes | 1 | 2003 | 14 | 0.050 |
Why?
| | Chromones | 1 | 2003 | 44 | 0.050 |
Why?
| | E2F3 Transcription Factor | 1 | 2023 | 10 | 0.050 |
Why?
| | Culturally Competent Care | 1 | 2024 | 64 | 0.050 |
Why?
| | Follicle Stimulating Hormone, Human | 1 | 2023 | 12 | 0.050 |
Why?
| | Gulf War | 1 | 2023 | 15 | 0.050 |
Why?
| | Immunohistochemistry | 1 | 2007 | 1731 | 0.050 |
Why?
| | Abortion, Spontaneous | 1 | 2024 | 104 | 0.050 |
Why?
| | Androstadienes | 1 | 2003 | 78 | 0.050 |
Why?
| | Cell Death | 1 | 2024 | 375 | 0.050 |
Why?
| | Thyroid Neoplasms | 1 | 2007 | 324 | 0.050 |
Why?
| | Protein Domains | 1 | 2024 | 288 | 0.050 |
Why?
| | Morpholines | 1 | 2003 | 124 | 0.050 |
Why?
| | Molecular Sequence Data | 4 | 2012 | 2923 | 0.050 |
Why?
| | Cluster Analysis | 2 | 2015 | 517 | 0.050 |
Why?
| | Acetophenones | 1 | 2001 | 14 | 0.050 |
Why?
| | Models, Molecular | 1 | 2007 | 1587 | 0.050 |
Why?
| | Benzopyrans | 1 | 2001 | 27 | 0.040 |
Why?
| | Carbazoles | 1 | 2001 | 56 | 0.040 |
Why?
| | Heterocyclic Compounds, 3-Ring | 1 | 2021 | 32 | 0.040 |
Why?
| | Naphthalenes | 1 | 2001 | 59 | 0.040 |
Why?
| | Focus Groups | 1 | 2024 | 539 | 0.040 |
Why?
| | Transcription Factor CHOP | 1 | 2021 | 33 | 0.040 |
Why?
| | Inflammation Mediators | 1 | 2024 | 513 | 0.040 |
Why?
| | Fat Emulsions, Intravenous | 1 | 2021 | 29 | 0.040 |
Why?
| | Immunoblotting | 1 | 2001 | 309 | 0.040 |
Why?
| | Indazoles | 1 | 2021 | 67 | 0.040 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2004 | 375 | 0.040 |
Why?
| | Adenoviridae | 1 | 2001 | 200 | 0.040 |
Why?
| | Self Efficacy | 1 | 2024 | 404 | 0.040 |
Why?
| | Genetic Fitness | 1 | 2021 | 57 | 0.040 |
Why?
| | Glucose Clamp Technique | 1 | 2021 | 196 | 0.040 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2021 | 117 | 0.040 |
Why?
| | Heat-Shock Proteins | 1 | 2021 | 142 | 0.040 |
Why?
| | NF-kappa B | 1 | 2024 | 678 | 0.040 |
Why?
| | Imidazoles | 1 | 2021 | 239 | 0.040 |
Why?
| | Aged | 1 | 2019 | 24024 | 0.040 |
Why?
| | Epigenesis, Genetic | 1 | 2024 | 639 | 0.040 |
Why?
| | DNA | 2 | 1997 | 1438 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2021 | 349 | 0.040 |
Why?
| | Pancreatic Neoplasms | 1 | 2007 | 857 | 0.040 |
Why?
| | Histones | 1 | 2024 | 632 | 0.040 |
Why?
| | Progestins | 1 | 2019 | 78 | 0.040 |
Why?
| | Self Report | 1 | 2023 | 839 | 0.040 |
Why?
| | ADP-Ribosylation Factors | 1 | 2018 | 18 | 0.040 |
Why?
| | Feeding Behavior | 1 | 2024 | 674 | 0.040 |
Why?
| | Cell Differentiation | 1 | 2006 | 1992 | 0.040 |
Why?
| | Indoles | 1 | 2001 | 414 | 0.040 |
Why?
| | Molecular Targeted Therapy | 1 | 2021 | 413 | 0.040 |
Why?
| | Academic Medical Centers | 1 | 2021 | 514 | 0.030 |
Why?
| | Dimerization | 1 | 2018 | 196 | 0.030 |
Why?
| | Enzyme Inhibitors | 1 | 2001 | 847 | 0.030 |
Why?
| | Recurrence | 1 | 2021 | 1084 | 0.030 |
Why?
| | Pyridines | 1 | 2021 | 494 | 0.030 |
Why?
| | Proto-Oncogene Protein c-ets-2 | 1 | 1997 | 4 | 0.030 |
Why?
| | Ectopic Gene Expression | 1 | 2016 | 5 | 0.030 |
Why?
| | Disease Management | 1 | 2021 | 622 | 0.030 |
Why?
| | ets-Domain Protein Elk-1 | 1 | 1996 | 12 | 0.030 |
Why?
| | Catalysis | 1 | 1997 | 319 | 0.030 |
Why?
| | Pituitary-Adrenal System | 1 | 2017 | 170 | 0.030 |
Why?
| | Transduction, Genetic | 1 | 1996 | 136 | 0.030 |
Why?
| | Hormones | 1 | 2016 | 140 | 0.030 |
Why?
| | Administration, Cutaneous | 1 | 2015 | 128 | 0.030 |
Why?
| | Oocyte Retrieval | 1 | 2015 | 12 | 0.030 |
Why?
| | Phosphoprotein Phosphatases | 1 | 2015 | 67 | 0.030 |
Why?
| | Neovascularization, Physiologic | 1 | 2016 | 182 | 0.030 |
Why?
| | Limit of Detection | 1 | 2015 | 91 | 0.030 |
Why?
| | Genes, Transgenic, Suicide | 1 | 2014 | 7 | 0.030 |
Why?
| | Absorptiometry, Photon | 1 | 2015 | 264 | 0.030 |
Why?
| | Trans-Activators | 1 | 1997 | 385 | 0.030 |
Why?
| | Protein-Tyrosine Kinases | 1 | 1997 | 431 | 0.030 |
Why?
| | Binding Sites | 1 | 1997 | 1313 | 0.030 |
Why?
| | Cellular Microenvironment | 1 | 2015 | 84 | 0.030 |
Why?
| | Recombinant Fusion Proteins | 1 | 1997 | 663 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2015 | 346 | 0.030 |
Why?
| | Chromosome Mapping | 1 | 1995 | 502 | 0.030 |
Why?
| | Ovary | 1 | 2015 | 223 | 0.030 |
Why?
| | Anions | 1 | 2013 | 32 | 0.030 |
Why?
| | Interleukin-1beta | 1 | 2015 | 378 | 0.030 |
Why?
| | Molecular Conformation | 1 | 2013 | 147 | 0.020 |
Why?
| | Chromatography, Liquid | 1 | 2015 | 448 | 0.020 |
Why?
| | Fatty Acids | 1 | 2015 | 444 | 0.020 |
Why?
| | Cardiovascular Diseases | 1 | 2024 | 2053 | 0.020 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2012 | 156 | 0.020 |
Why?
| | Genetic Therapy | 1 | 2014 | 314 | 0.020 |
Why?
| | Heterografts | 1 | 2012 | 135 | 0.020 |
Why?
| | Gene Library | 1 | 2012 | 118 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2015 | 1244 | 0.020 |
Why?
| | Protein Kinases | 1 | 1992 | 308 | 0.020 |
Why?
| | Nitriles | 1 | 2011 | 176 | 0.020 |
Why?
| | Male | 4 | 2017 | 68260 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2015 | 873 | 0.020 |
Why?
| | Triazoles | 1 | 2011 | 156 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2024 | 10923 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2011 | 768 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2012 | 819 | 0.020 |
Why?
| | Receptors, Pituitary Hormone-Regulating Hormone | 1 | 2006 | 8 | 0.020 |
Why?
| | Receptors, Neuropeptide | 1 | 2006 | 12 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2017 | 5520 | 0.020 |
Why?
| | Transcriptome | 1 | 2012 | 967 | 0.010 |
Why?
| | Prognosis | 1 | 2012 | 3984 | 0.010 |
Why?
| | Liver | 1 | 1992 | 1805 | 0.010 |
Why?
| | Suppression, Genetic | 1 | 2003 | 24 | 0.010 |
Why?
| | Genes, Dominant | 1 | 2003 | 97 | 0.010 |
Why?
| | Genetic Vectors | 1 | 2004 | 336 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2012 | 4315 | 0.010 |
Why?
| | Amino Acid Sequence | 2 | 1997 | 2155 | 0.010 |
Why?
| | Phosphothreonine | 1 | 1997 | 6 | 0.010 |
Why?
| | Sequence Alignment | 1 | 1997 | 360 | 0.010 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1997 | 391 | 0.010 |
Why?
| | Structure-Activity Relationship | 1 | 1997 | 575 | 0.010 |
Why?
| | Drosophila Proteins | 1 | 1997 | 201 | 0.010 |
Why?
| | Nerve Tissue Proteins | 1 | 1997 | 600 | 0.010 |
Why?
| | Biological Evolution | 1 | 1997 | 479 | 0.010 |
Why?
| | Chromatography, Ion Exchange | 1 | 1992 | 53 | 0.010 |
Why?
| | Chromatography, Gel | 1 | 1992 | 130 | 0.010 |
Why?
| | Rats, Inbred Strains | 1 | 1992 | 345 | 0.010 |
Why?
| | Molecular Weight | 1 | 1992 | 327 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1992 | 336 | 0.010 |
Why?
| | Cytosol | 1 | 1992 | 227 | 0.010 |
Why?
| | Substrate Specificity | 1 | 1992 | 383 | 0.010 |
Why?
| | Peptides | 1 | 1997 | 976 | 0.010 |
Why?
| | Oligopeptides | 1 | 1992 | 266 | 0.010 |
Why?
| | Cells, Cultured | 1 | 1997 | 4181 | 0.000 |
Why?
| | Kinetics | 1 | 1992 | 1645 | 0.000 |
Why?
|
|
Bradford's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|